Long Term, Follow-on Study of Lomitapide in Patients With Homozygous Familial Hypercholesterolemia
Status:
Completed
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
This was a long term follow on study to assess the continued long term safety and efficacy of
lomitapide in patients with homozygous familial hypercholesterolemia.